Actively Recruiting
Real-World Registry Study of Integrated Traditional Chinese and Western Medicine for Obesity
Led by Hubei Hospital of Traditional Chinese Medicine · Updated on 2026-03-04
10000
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
Sponsors
H
Hubei Hospital of Traditional Chinese Medicine
Lead Sponsor
U
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
Obesity is a major risk factor for cardiovascular disease, diabetes, cancer, and other chronic conditions. Due to its complex etiology and frequent comorbidities, effective obesity management requires comprehensive and individualized approaches. This study is a multicenter, prospective, real-world registry designed to evaluate integrated traditional Chinese medicine (TCM) and Western medicine interventions for obesity. The study will enroll at least 10,000 individuals with obesity from urban and rural populations. Multimodal data, including electronic medical records, laboratory test results, imaging data, and lifestyle information, will be collected. The effectiveness of integrated TCM and Western medicine interventions will be assessed across different age groups, disease stages, and obesity-related constitution types. In addition, disease progression patterns and key prevention and treatment points will be explored. Health economic analyses will be conducted to evaluate the cost-effectiveness of different obesity management strategies, providing real-world evidence to support public health policy and the optimization of integrated obesity prevention and management approaches.
CONDITIONS
Official Title
Real-World Registry Study of Integrated Traditional Chinese and Western Medicine for Obesity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years and above, gender not restricted
- Weight fluctuation within the last 3 months is 64 5%
- Body mass index (BMI) is 65 28.0 kg/m2
- Good compliance and willingness to follow the follow-up schedule
- Agree to sign the informed consent form
You will not qualify if you...
- Severe diseases in heart, liver, lungs, kidneys, brain, blood, neuro-psychiatric system, or other vital organs
- Secondary obesity caused by other diagnosed disorders such as hypothalamic or pituitary inflammation, tumors, trauma, Cushing's syndrome, hypothyroidism, hypogonadism, or polycystic ovary syndrome
- Obesity caused by drugs or treatments for other conditions (iatrogenic obesity)
- Pregnant or breastfeeding women
- Investigator considers participant unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hubei Provincial Hospital of Traditional Chinese Medicine
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
C
ChenGang Professor ChenGang, Doctor
CONTACT
Z
ZhuHui ZhuHui, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here